CLOSING THE GAP FROM SCIENCE TO REAL LIFE SETTING ...
INSULIN MANAGEMENT IN T2DM PATIENTS

van Swieten Hall

Tuesday, 29 September 2009, 09:00 - 14:00 (Morning)

Chairman:	Philip Home, UK
09:00 - 09:10	Introduction Philip Home, UK
09:10 - 09:25	Insulin long term safety: Review of pre clinical evidence Hans Häring, DE
09:25 - 09:40	Insulin long term safety: Review of epidemiological evidence Peter Boyle, FR
09:40 - 09:55	Insulin long term safety: Review of controlled clinical trials Philip Home, UK
09:55 - 10:25	Q&A / panel discussion Hans Häring, DE, Peter Boyle, FR, Philip Home, UK, Martin Murphy, US
10:25 - 10:50	break
10:50 - 11:05	Daily Clinical Practice: the reality is not what we dream of Melanie Davies, UK
11:05 - 11:20	Translating basic science into patient benefit Francesca Porcellati, IT
11:20 - 11:40	What can we expect of insulin initiation in T2D? Review of the medical evidence Vivian Fonseca, US
11:40 - 11.55	What can we expect of insulin initiation in T2D? Review of the real life data Jack. Leahy, US
11:55 - 12:10	What can we expect of insulin initiation in T2D? Review of the cost effectiveness data Bill Herman, US
12:10 - 12:30	Q&A and panel discussion
12:30 - 12:40	Closing remarks Philip Home, UK
12:40	End
12.40 - 14.00	Lunch

For further information please contact:
Email: Diabete2009@sanoﬁ-aventis.com